No, McCoy is very correct, the trade name "Bioamber" sold to LCY Biosciences. It has been posted here multiple times. Reading the court documents instead of choosing paragraphs may help. Then again, you would have to understand what you're reading. Post # 118119 - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165099543
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.